Lv11
10 积分 2023-09-10 加入
Endocrine Diseases and the Liver
3小时前
待确认
Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy
3小时前
已关闭
A Scoping Review of the Classification, Diagnosis, and Management of Hepatic Adenomas
3小时前
已关闭
Metabolic Syndrome in Cushing's Syndrome Patients
4小时前
已关闭
Clinical associations between thyroid and liver diseases
5小时前
已完结
Impact of periprocedural subcutaneous parathyroid hormone on control of hypocalcaemia in APS‐1/APECED patients undergoing invasive procedures
6小时前
已完结
Endocrine and liver interaction: the role of endocrine pathways in NASH
8小时前
已完结
The mechanisms of lysophosphatidylcholine in the development of diseases
22天前
已完结
Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement
23天前
已完结
Individualized lipid-lowering therapy to further reduce residual cardiovascular risk
23天前
已关闭
皖公网安备34019202002308
